1. 1. 2018; PubMed.gov; Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?1. 2018; PubMed.gov; Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis? https://www.ncbi.nlm.nih.gov/pubmed/29308975s://www.ncbi.nlm.nih.gov/pubmed/29308975
14. 12. 2018; DMSG; ULTIPLE SKLEROSE.TV: RUMPFÜBUNGEN BEI MS https://www.dmsg.de/multiple-sklerose-news/dmsg-aktuell/multiple-sklerosetv-rumpfuebungen-bei-ms/ 14. 12. 2018; ms-uk; MS patients who are stable on interferon therapy show better outcomes than those who switch https://www.ms-uk.org/ms-patients-who-are-stable-interferon-therapy-show-better-outcomes-those-who-switch 13. 12. 2018; MSIF; Results Published from Australian HSCT Bone Marrow Stem Cell Transplantation Trial in MS https://www.nationalmssociety.org/About-the-Society/News/Results-Published-from-Australian-HSCT-Bone- Marrow?feed=AllNationalNews 13. 12. 2018; aerztezeitung.de; Von Fingolimod profitieren auch Kinder mit MS https://www.aerztezeitung.de/medizin/krankheiten/neuro-psychiatrische_krankheiten/multiple_sklerose/article/976845/multiple- sklerose-fingolimod-profitieren-kinder-ms.html?wt_mc=nl.upd.AEZ_NL_NEWSLETTER.2018-12-13.Multiple+Sklerose.x 7. 12. 2018; DMSG; MEHR ALS JEDER ZEHNTE MULTIPLE SKLEROSE-ERKRANKTE IST VON AUGENBEWEGUNGSSTÖRUNGEN BETROFFEN https://www.dmsg.de/multiple-sklerose-news/ms-forschung/mehr-als-jeder-zehnte-multiple-sklerose-erkrankte-ist-von- augenbewegungsstoerungen-betroffen/ 7. 12. 2018; amsel.de; Was kann ich noch tun? https://www.amsel.de/multiple-sklerose-news/medizin/was-kann-ich-noch-tun/ 5. 12. 2018; ms-uk; Real world study tests the effects of weather and temperature on MS patients treated with Rebif https://www.ms-uk.org/real-world-study-tests-effects-weather-and-temperature-ms-patients-treated-rebif 5. 12. 2018: e-med forum; Pflanzenschutzmittel können Nerven schädigen http://www.emed-ms.de/index.php?id=533&tt_news=3075 4. 12. 2018; MSIF; FDA Issues Warning About Rare Risk of Stroke and Artery Wall Tears with Use of Lemtrada https://www.nationalmssociety.org/About-the-Society/News/FDA-Issues-Warning-About-Rare-Risk-of-Stroke-and- A?feed=AllNationalNews 4. 12. 2018; pubmed. gov; Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). https://www.ncbi.nlm.nih.gov/pubmed/30515631 4. 12. 2018; e-med forum; Schalter für die Regeneration von Nervenzell-Isolierschicht entdeckt http://www.emed-ms.de/index.php?id=533&backPID=433&tt_news=3078 4. 12. 2018; Ärzte Zeitung online,; Ozanimod - Neue MS-Arznei punktet in Phase III https://www.aerztezeitung.de/medizin/krankheiten/neuro-psychiatrische_krankheiten/multiple_sklerose/article/977263/ozanimod- neue-ms-arznei-punktet-phase-iii.html?wt_mc=nl.upd.AEZ_NL_NEWSLETTER.2018-12-04.Multiple+Sklerose.x Novemer 2018 Oktober 2018 September 2018 August 2018 Juli 2018 Juni 2018 Mai 2018 April 2018 März 2018 Feb. 2018 Jan. 2018 Dez. 2017 Nov. 2017 Okt. 2017 Sept. 2017 August 2017 Juli 2017 Juni 2017 Mai 2017 April 2017 März 2017 Februar 2017 Jänner 2017 Dezember 2016 November 2016 Oktober 2016 September 2016 August 2016 Juli 2016 Juni 2016 http://www.dmsg.de/multiple-sklerose-news/ http://www.amsel.de/multiple-sklerose-news/8 http://www.emed-ms.de/News.news.0.html http://www.ms-life.de/mslife/ms-nachrichten/aktuelles/content-150952.html http://www.aktiv-mit-ms.de/ms-news/ http://www.leben-mit-ms.de/de/patientenundangehoerige/nachrichten/page.html http://www.msif.org/en/research/ms_research_news/index.html http://idw-online.de/pages/de/ticker http://www.pressemitteilungen-online.de/?s=multiple+sklerose http://www.nature.com/ http://www.thelancet.com/journals/lancet/issue/current http://www.neurology.org/ http://www.nejm.org/medical-index http://www.jneurosci.org/ http://www.clineu-journal.com/ http://www.ncbi.nlm.nih.gov/pubmed http://msj.sagepub.com/ http://www.ms-uk.org/MSnews/ Kennen Sie einen informativen MS-Link? Lassen Sie ihn mich bitte wissen! Ein Geschenk ist genau so viel wert wie die Liebe, mit der es ausgesucht worden ist. Thyde Monnier Zur Startseite
http://georgieff.at/
Herzlich willkommen auf georgieff.at,
Sie haben eine gute Wahl getroffen.
Das Lesen dieser Homepage ist gratis, aber nicht umsonst.
Hier erfahren Sie über Fakten, nicht von “Gschichtln”.
Wie auch immer -
kein Facebook, kein Twitter, kein Instagram,
so free
… Anm.:
Junge Menschen verbringen bis zu sieben Stunden täglich mit ihrem
Smartphone.  Aber bin ja nicht mehr jung…
Der Dalai Lma sagt; “Wenn man die Ruhe nicht in sich selbst findet, ist es
umsonst, sie anderswo zu suchen.”
Institut für Koreanische Handmassage IKHM
Die
Website für Koreanische Handmassage
Verein Weak MuSkle VWM
Die
aktuellste
Website für Multiple Sklerose
Sollten Sie sich fragen, ob diese Homepage von einer Firma betrieben wird, die ihre
Produkte bewirbt oder von einem selbst betroffenen Arzt, der seinem hippokratischen Eid
verpflichtet ist, lesen Sie einfach weiter.
Hier werden Sie nicht aufgefordert, mit
Therapietreue ein bestimmtes Medikament zu konsumieren, sondern Ihr Hirn
einzuschalten und das Heft selbst in die Hand zu nehmen.
Home Koreanische Handmassage Weak MuSkle Bücher Vorträge Impressum Haftung
MS-News, Infos und Links
Neue und wichtige Studien, Publikationen und Links zu MS Stand 31. 10. 2019 Wie Sie wissen, verläuft jede Entwicklung vom Primitiven über Kmpizietes hin zum Einfachen. Wir werden sehen… - Die Zeit trifft das Urteil (Tempus ferit iudicum). Sie benötigen in Englisch-Wörterbuch zur Kontrolle? https://translate.google.at/#en/de/When%20I%20open%20my%20linen%20closet%20this%20morning oder bevorzugen Sie den Google translator ((https://translate.google.at/#view=home&op=translate&sl=en&tl=de&text=german)? Oktober 2019 31. 10. 2019; multiplesclerosisnewstoday.com; Medicinal Cannabinoids Not Effective for Mental Disorders, Small Relief on MS Anxiety, Analysis Suggests https://multiplesclerosisnewstoday.com/news-posts/2019/10/29/insufficient-evidence-that-medicinal-cannabinoids- improve-mental-health/ 30. 10. 2019; ms -uk; First private clinic gets Care Quality Commission approval for medical cannabis prescriptions https://www.ms-uk.org/first-private-clinic-gets-care-quality-commission-approval-medical-cannabis-prescriptions 28. 10. 2019; https://multiplesclerosisnewstoday.com, AP-1 Transcription Factor Family is Critical for Healthy T-cell Development, Study Says https://multiplesclerosisnewstoday.com/news-posts/2019/10/25/scientists-find-molecular-key-to-body-making-healthy- t-cells/ 25. 10. 2019; multiplesclerosisnewstoday.cpm; Higher Intellectual Ability, Early-life Physical Activity May Protect Against Cognitive Impairment in MS, Study Suggests https://multiplesclerosisnewstoday.com/news-posts/2019/10/22/cognitive-impairment-in-multiple-sclerosis-an- exploratory-analysis-of-environmental-and-lifestyle-risk-factors/ 25. 10. 2019; multiplesclerosisnewstoday.cpm; Twice Daily Dosing and Side Effects Top Reasons Patients Seen to Stop Tecfidera in Small Study https://multiplesclerosisnewstoday.com/news-posts/2019/10/18/assessing-barriers-to-adherence-with-the-use-of- dimethyl-fumarate-in-multiple-sclerosis/ 24. 10. 2019; .nature.com; Immune reconstitution therapies: concepts for durable remission in multiple sclerosis https://www.nature.com/articles/s41582-019-0268-z 24. 10. 2019; NMSS; Society-Supported Collaborators Show Validity of Measures that Track MS Progression https://www.nationalmssociety.org/About-the-Society/News/Society-Supported-Collaborators-Show-Validity-of-M 24. 10. 2019; ; multiplesclerosisnewstoday.cpm; Need to Know: How MS Affects Memory https://multiplesclerosisnewstoday.com/news-posts/2019/09/25/memory-fatigue-sleep-disorders-need-know/ 24. 10. 2019; MSNT; Potential RRMS Fumarate Treatment Free of ‘Flush’ Effect to Enter Trial in 2020, Vitalis Says https://multiplesclerosisnewstoday.com/news-posts/2019/10/22/vitalis-pharmaceuticals-anticipates-launch-of-novel- low-flush-fumarate-by-2021/ 23. 10. 2019; multiplesclerosisnewstoday.com; MS Among Research and Discussion Topics at 24th World Congress of Neurology https://multiplesclerosisnewstoday.com/news-posts/2019/10/21/new-research-on-climate-change-and-the-brain-the- relationship-between-stroke-and-dementia-advances-in-epilepsy-and-ms-among-the-brain-health-initiatives-unveiled- at-24th-world-congress-of-neurology/ 23. 10. 2019; amsel.de; WIRKSTOFF-STUDIEN - Abwechslungsreicher und aktiver Lebensstil hilft Nerven beim Regenerieren
https://www.amsel.de/multiple-sklerose-news/medizin/abwechslungsreicher-lebensstil-hilft-nerven-beim-regenerieren/ 22. 10. 2019; multiplesclerosisnewstoday.com; Endothelin-1 a Potential Biomarker of Severity and Recovery from Optic Neuritis in MS, Study Suggests https://multiplesclerosisnewstoday.com/news-posts/2019/10/14/increased-levels-of-endothelin-1-in-cerebrospinal- fluid-are-a-marker-of-poor-visual-recovery-after-optic-neuritis-in-multiple-sclerosis-patients/ 22. 10. 2019; multiplesclerosisnewstoday.com; SPMS and Diet: What Foods Can Help? https://multiplesclerosisnewstoday.com/health-insights/2019/10/16/spms-and-diet-what-should-eat-and-not-eat/ 22. 10. 2019; multiplesclerosisnewstoday.com; Long-term Gilenya Treatment Safe and Effective for Relapsing MS Patients, Phase 3 Trial Shows https://multiplesclerosisnewstoday.com/news-posts/2019/10/16/extended-treatment-with-fingolimod-for-relapsing- multiple-sclerosis-the-14-year-longterms-study-results/ 21. 10. 2019; ms-uk; Night shift work may increase risk for MS https://www.ms-uk.org/night-shift-work-may-increase-risk-ms 18. 10. 2019; multiplesclerosisnewstoday.coM, #ECTRIMS2019 – Are Injectables Inappropriate for Active Relapsing MS Treatment? https://multiplesclerosisnewstoday.com/news-posts/2019/09/18/ectrims2019-burning-debate-sept-11/ 17. 10. 2019; e-med forum; MS: Real-World-Daten zeigen anhaltende Wirksamkeit von Dimethylfumarat und Natalizumab http://www.emed-ms.de/index.php?id=533&tt_news=3184 17. 10. 2019; e-med forum; MS: Real-World-Daten zeigen anhaltende Wirksamkeit von Dimethylfumarat und Natalizumab http://www.emed-ms.de/index.php?id=533&tt_news=3184 17. 10. 2019;; e-med forum; Endlich Erleichterungen für die Verordnung von Cannabis als Medizin http://www.emed-ms.de/index.php?id=533&tt_news=3186 17. 10. 2019, MSNT; Rituximab Linked to Greater Risk of Infections in MS Patients in Real-world Swedish Study https://multiplesclerosisnewstoday.com/news-posts/2019/10/08/infection-risks-among-patients-with-multiple-sclerosis-treated-with- fingolimod-natalizumab-rituximab-and-injectable-therapies/ 16. 10. 2019; hhu; Neues Medikament zur Behandlung der Multiplen Sklerose https://www.uni-duesseldorf.de/home/startseite/news-detailansicht-inkl-gb/article/neues-medikament-zur-behandlung-der- multiplen-sklerose.html?cHash=b1317964ef4cfac52681148f17628377 15. 10. 2019; /multiplesclerosisnewstoday.com; Immunic Therapeutics Fully Enrolls Phase 2 Trial of Oral IMU-838, Potential RRMS Treatment https://multiplesclerosisnewstoday.com/news-posts/2019/10/11/immunic-inc-announces-completion-of-enrollment-for-its-phase-2- emphasis-trial-of-imu-838-in-patients-with-relapsing-remitting-multiple-sclerosis/ 14. 10. 2019; MSIF; Tawasol – October 2019 issue https://www.msif.org/news/2019/10/14/tawasol-october-2019-issue/
14. 10. 2019; .aktiv-mit-ms.de; Cannabis bei MS https://www.aktiv-mit-ms.de/leben/artikel/cannabis-bei-ms/ 14. 10. 2019; ms-uk; People with MS more likely to have other conditions https://www.ms-uk.org/people-ms-more-likely-have-other-conditions 14. 10. 2019; multiplesclerosisnewstoday.com; Decades of Night Work Tied to Nearly 3 Times Higher MS Risk, Studies in Nurses Suggest https://multiplesclerosisnewstoday.com/news-posts/2019/08/29/get-pdf-rotating-night-shift-work-and-risk-of-multiple-sclerosis-in- the-nurses-health-studies/ 14. 10. 2019; multiplesclerosisnewstoday.com; Metformin Works to Promote Remyelination in Ways Similar to Fasting, Study Says https://multiplesclerosisnewstoday.com/news-posts/2019/10/11/diabetes-drug-metformin-promotes-myelin-repair-in-rats/ 11. 10. 2019; ms-uk; New ad campaign raises awareness of MS https://www.ms-uk.org/new-ad-campaign-raises-awareness-ms 10. 10. 2019; multiplesclerosisnewstoday; Blocking LRP1 May Halt Inflammation, Promote Remyelination, Mouse Study Suggests https://multiplesclerosisnewstoday.com/news-posts/2019/10/07/blocking-lrp1-halts-inflammation-promotes-remyelination-mouse- study/ 10. 10. 2019; multiplesclerosisnewstoday; Need to Know: MS and Respiratory Viruses https://multiplesclerosisnewstoday.com/news-posts/2019/09/17/need-to-know-about-ms-and-respiratory-viruses/ 8. 10. 2019; amsel.de; Ein Biomarker, viele Messwerte https://www.amsel.de/multiple-sklerose-news/medizin/ein-biomarker-viele-messwerte/ 8. 10. 2019; MSNT; Targeting Toxic T Helper Cells – Those with CXCR6 Receptor – Seen to Prevent MS in Mouse Model https://multiplesclerosisnewstoday.com/news-posts/2019/10/04/targeting-certain-rogue-t-cells-prevents-and-reverses-multiple- sclerosis-in-mice/ 7. 10. 2019; e-med forum, MS: Langzeitwirksamkeit von Cladribin-Tabletten bestätigt http://www.emed-ms.de/index.php?id=533&tt_news=3183 7. 10. 2019; e-med forum; Paradigmenwechsel in der MS-Therapie – Heilung durch Stammzelltransplantation? http://www.emed-ms.de/index.php?id=533&tt_news=3180 7. 10. 2019; ms-uk; New head-to-head phase 3 study shows ponesimod more effective than teriflunomide https://www.ms-uk.org/new-head-head-phase-3-study-shows-ponesimod-more-effective-teriflunomide 7. 10. 2019; ms-uk; New head-to-head phase 3 study shows ponesimod more effective than teriflunomide https://www.ms-uk.org/new-head-head-phase-3-study-shows-ponesimod-more-effective-teriflunomide 7. 10. 2019; MSIF; Fats, genes and MS progression https://www.msif.org/news/2019/10/07/fats-genes-and-ms-progression/
7. 10. 2019; amsel.de; Kindliche MS, progrediente MS, Remyelinisierung, MRT, Big Data und Künstliche Intelligenz https://www.amsel.de/multiple-sklerose-news/medizin/kindliche-ms-progrediente-ms-remyelinisierung-mrt-big-data-und- kuenstliche-intelligenz/ 7. 10. 2019; e-med forum; MS: Langzeitwirksamkeit von Cladribin-Tabletten bestätigt http://www.emed-ms.de/index.php?id=533&tt_news=3183 7. 10. 2019; MSIF; International study identifies protein networks that underlie MS risk https://www.msif.org/news/2019/10/07/international-study-identifies-protein-networks-that-underlie-ms-risk/ 7. 10. 2019; MSIF; Non-invasive method helps the survival of myelin-producing cells https://www.msif.org/news/2019/10/07/non-invasive-method-helps-the-survival-of-myelin-producing-cells/ 7. 10. 2019; MSIF; Fats, genes and MS progression https://www.msif.org/news/2019/10/07/fats-genes-and-ms-progression/ 7. 10. 2019, ms-uk; Diabetes drug may halt MS progression https://www.ms-uk.org/diabetes-drug-may-halt-ms-progression 7. 10. 2019, MSNT; MS News that Caught My Eye Last Week: Rituximab vs. Ocrevus https://multiplesclerosisnewstoday.com/columns/2019/10/04/ms-news-that-caught-my-eye-last-week-rituximab-versus-ocrevus/ 7. 10. 2019, MSNT; RRMS Patients Not Using DMTs More Likely to Have Been Misdiagnosed, Cite Poorer Relationships with Doctors, Survey Says https://multiplesclerosisnewstoday.com/news-posts/2019/10/03/ms-survey-finds-positive-hcp-relationships-proactive-medication- interest-likely-indicators-of-dmt-use/ 4. 10. 2019; DMSG; NEU E BROSCHÜRE: LEITFADEN "IHR WEG ZUR PFLEGELEISTUNG" BIETET RECHTLICHE HILFESTELLUNG https://www.dmsg.de/multiple-sklerose-news/dmsg-aktuell/neue-broschuere-leitfaden-ihr-weg-zur-pflegeleistung-bietet-rechtliche- hilfestellung/ 4. 10. 2019; MSNT; #ECTRIMS2019 – Is Rituximab a Reasonable Option for MS Patients? No, Researcher Says https://multiplesclerosisnewstoday.com/2019/09/27/ectrims-2019-rituximab-not-reasonable-option-to-ocrevus/ 4. 10. 2019; MSNT; #ECTRIMS2019 – Is Rituximab a Reasonable Option for MS Patients? Yes, Researcher Says https://multiplesclerosisnewstoday.com/news-posts/2019/09/23/ectrims2019-is-rituximab-reasonable-option-for-ms-patients-yes/ 3. 10. 2019; MSNT; Need to Know: How to Manage MS Pain https://multiplesclerosisnewstoday.com/news-posts/2019/09/10/need-to-know-how-to-manage-ms-pain/ 2. 10. 2019; multiplesclerosisnewstoday.com; NFIA Protein Essential to Astrocytes, Brain Cells Active in Spinal Cord Repair and Remyelination, Study Suggests https://multiplesclerosisnewstoday.com/news-posts/2019/09/26/the-unexpected-functional-diversity-of-reactive-astrocytes/ 1. 10. 2019; MSNT; As MS research evolves, a new focus on brain preservation comes to light https://multiplesclerosisnewstoday.com/sponsored-content/2019/10/01/as-ms-research-evolves-a-new-focus-on-brain- preservation-comes-to-light-p-stylefont-size14pxsponsored-postp/ 1. 10. 2018; multiplesclerosisnewstoday; Detailed Genetic Map Implicates Broad Immune Cell Involvement in MS, Reports Risk Variant in X Chromosome https://multiplesclerosisnewstoday.com/news-posts/2019/09/27/genomic-map-implicates-broad-immune-cell-involvement-in- multiple-sclerosis/ Teenager sind Mädchen, die mehr über die Pille wissen als ihre Mütter über die Geburt. Dustin Hoffman Zur Startseite